Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease

03 Jun 2019

Elad Asher

Reviewer

Elad Asher

Reviewer

Salvatore Brugaletta
Prognostic implications of plaque characteristics and stenosis severity in patients with CAD

Highlights of EuroPCR 2019 - PCR's Got Talent winner

03 Jun 2019 – From EuroPCR 2019

Since its creation, PCR's Got Talent has riveted the attention of young investigators worldwide! Join EuroPCR Course Director William WIJNS as he speaks with 2017 winner Nina Van der Hoeven from the Netherlands discussing how the competition helped her improve her presentation skills, slides and communication...

2019 PCR's Got Talent

Quality in the Cathlab: What is needed to establish a quality program (NAP)

Lynne Hinterbuchner, from the Salzburg University Clinic in Austria asks David Sparv, the Chief Nursing Officer for 5 hospitals in Sweden about quality in the Cathlab. Education and training for Cathlab nurses and allied professionals needs to be standardised.  The European core curriculum leading to certification...

Quality in the Cathlab (NAP)

Post-bypass PCI: challenges and solutions

24 May 2019 – From EuroPCR 2019

Consult this session to learn all about the challenges and solutions regarding post-bypass PCI, with compelling clinical cases involving complex anatomies and innovative ways to cope with them.

Post-bypass PCI: challenges and solutions

What every interventional cardiologist should know about new cardiovascular drugs

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the impact of new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9 and SGLT-2 inhibitors, GLP1 agonists, and more!

What every interventional cardiologist should know about new cardiovascular drugs

High-bleeding risk PCI patients enrolled in ongoing clinical trials

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about high-bleeding risk PCI patients: how to identify them, how to successfully adapt PCI technique and how to select the optimal antiplatelet treatment post-PCI according to the patient's bleeding and thrombotic risks.

High-bleeding risk PCI patients enrolled in ongoing clinical trials

Innovations in imaging and physiology

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about various studies and trials regarding innovations in imaging and physiology, such as the TrackCath system, the photoacoustic imaging of lipids in coronary atherosclerosis, and more!

Innovations in imaging and physiology

Clinical value of DEB for coronary intervention

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the clinical value of drug-eluting baloons thanks to various studies and trials: PREVAIL, ELEGANT, and more!

Clinical value of DEB for coronary intervention

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

23 May 2019 – From EuroPCR 2019

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

Clinical use of intracoronary imaging - EAPCI expert consensus

Tom Johnson talks to Giulio Guagliumi about the EAPCI expert consensus document on intracoronary imaging that he presented at EuroPCR 2019. He explains that the document “acknowledges difficulties we as an interventional community have in understanding how best to apply this exciting technology to ensure the...

Clinical use of intracoronary imaging - EAPCI expert consensus